51 JFK Parkway, Short Hills, NJ 07078
Monday, September 14, 2026

Insights & Analysis

Practical guidance on PBM audits, federal investigations, compounding defense, DEA enforcement, telehealth compliance, and the regulatory pressures facing pharmacies and providers nationwide.

More articles — Page 10

Page 10 of 70 · 635 articles
Reverse False Claims Liability for Retaining an Overpayment
Healthcare Fraud Defense

Reverse False Claims Liability for Retaining an Overpayment

Retaining a known Medicare or Medicaid overpayment past the 60-day deadline can itself be a False Claims Act violation under the r…

Anthony MahajanSep 4, 2026
Appealing a UPIC Overpayment Determination
Payor Disputes

Appealing a UPIC Overpayment Determination

UPIC overpayment determinations trigger Medicare's five-level appeal process, with strict 30- and 60-day windows controlling wheth…

Anthony MahajanSep 4, 2026
Florida regulatory scrutiny of CVS Caremark PBM practices
PBM Audits & Defense

Florida Attorney General Launches Investigation Into CVS Caremark: What It Means for Independent Pharmacies

Florida’s Attorney General issued a Civil Investigative Demand to CVS Health and Caremark, underscoring intensifying scrutiny of P…

Anthony MahajanSep 3, 2026
Independent pharmacy retained in its PBM network after a termination reversal
PBM Audits & Defense

Health Law Alliance Successfully Reverses PBM Network Termination for a California Independent Pharmacy

Health Law Alliance obtained a complete reversal of a PBM network termination for a California independent pharmacy, preserving it…

Anthony MahajanSep 3, 2026
PBM audit documents under review
PBM Audits & Defense

PBM Audit Defense Lawyer Insights: Avoiding the Top PBM Audit Traps That Lead to Network Termination

Six common PBM audit-response mistakes that can escalate into recoupment, network termination, or a broader government investigati…

Anthony MahajanSep 3, 2026
Unbranded pharmacy and laboratory vials beside legal reference books with a state capitol in the background
Compounding Pharmacy

State Professional Licensing Boards Take Aim at Peptides

State medical, nursing and pharmacy boards are taking an aggressive stance against clinical use of peptides despite FDA’s recent…

Martha RumoreSep 3, 2026
Skin Substitute Distributor Arrangements and Enforcement
Wound Care

Skin Substitute Distributor Arrangements and Enforcement

A $309 million DOJ settlement shows how distributor commissions and pricing spreads on skin substitutes become Anti-Kickback Statu…

Alison GoldmanSep 3, 2026
Selective Versus Excisional Debridement Documentation
Wound Care

Selective Versus Excisional Debridement Documentation

Selective and excisional debridement pay differently and require different proof. What the operative note must show, and why wound…

Alison GoldmanSep 3, 2026
Medically Unnecessary Services as an FCA Theory
Healthcare Fraud Defense

Medically Unnecessary Services as an FCA Theory

Medical necessity splits the federal circuits on what counts as false under the FCA, turning a documented clinical judgment into t…

Anthony MahajanSep 3, 2026